Ian Crosbie

Chief Executive Officer

Company Overview

“Sequana Medical is at an exciting phase in its development with clear ambitions to accelerate its commercial growth and innovation. We continue to invest in our alfapump® and alfapump® DSR technologies to bring these innovative treatment options to a broader patient group and address important unmet medical needs, while creating value for shareholders.”

Share Price


ISIN: XXXXXXXXXXXXX-XXXX Updated at 11:05:33

EURO 22.40



For more information, please consult Euronext

Investor Tool Kit

2018 Annual Report

Download .pdf

Investor presentation

Download .pdf

Company Fact Sheet

Download .pdf

alfapump DSR Fact Sheet

Download .pdf

Financial Calendar

September 4, 2019

Half year 2019 Business Update & Financial Results

Latest News

Latest News during Our Offering period
Other Latest News

We would like to use cookies to better understand your use of this website. This enables us to improve your future experience on our website. Detailed information about the use of cookies on this website and how you can manage or withdraw your consent at any time can be found in our
Privacy & Cookie Policy

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.